Advertisements

Reckitt to pay $1.4 billion to end opioid addiction treatment probes

Reckitt to pay $1.4 billion to end opioid addiction treatment probes.....»»

Category: global-financeSource: reutersJul 11th, 2019

Reckitt to pay $1.4 billion to end opioid addiction treatment probes

Reckitt to pay $1.4 billion to end opioid addiction treatment probes.....»»

Category: global-financeSource: reutersJul 11th, 2019

Reckitt to pay $1.4 billion to end long-running Indivior probes

Reckitt to pay $1.4 billion to end long-running Indivior probes.....»»

Category: global-financeSource: reutersJul 11th, 2019

Indivior loses appeal to block generic Suboxone opioid treatments

Indivior loses appeal to block generic Suboxone opioid treatments.....»»

Category: global-financeSource: reutersJul 12th, 2019

Indivior shares plummet, Reckitt hurt on U.S. charges over opioid prescriptions

Indivior shares plummet, Reckitt hurt on U.S. charges over opioid prescriptions.....»»

Category: global-financeSource: reutersApr 10th, 2019

U.S. charges pummel drugmaker Indivior, hurt Reckitt

U.S. charges pummel drugmaker Indivior, hurt Reckitt.....»»

Category: global-financeSource: reutersApr 10th, 2019

U.S. indicts Indivior over Suboxone opioid treatment marketing

U.S. indicts Indivior over Suboxone opioid treatment marketing.....»»

Category: global-financeSource: reutersApr 9th, 2019

U.S. top court rejects bid to block Indivior opioid drug copycat

U.S. top court rejects bid to block Indivior opioid drug copycat.....»»

Category: global-financeSource: reutersFeb 19th, 2019

Indivior loses U.S. district court battle, copycat launches imminent

Indivior loses U.S. district court battle, copycat launches imminent.....»»

Category: global-financeSource: reutersFeb 12th, 2019

Indivior temporarily stops rival Alvogen"s generic launch

Indivior temporarily stops rival Alvogen"s generic launch.....»»

Category: global-financeSource: reutersJan 25th, 2019

Indivior plans cheaper opioid addiction drug if rivals launch copycats

Indivior plans cheaper opioid addiction drug if rivals launch copycats.....»»

Category: global-financeSource: reutersDec 18th, 2018

Indivior to launch cheaper opioid addiction drug; maintains forecast

Indivior to launch cheaper opioid addiction drug; maintains forecast.....»»

Category: global-financeSource: reutersDec 18th, 2018

Indivior says wins fresh hold on Suboxone copy

Indivior says wins fresh hold on Suboxone copy.....»»

Category: global-financeSource: reutersDec 12th, 2018

Indivior sticks to FY outlook, warns of hit from generic rival

Indivior sticks to FY outlook, warns of hit from generic rival.....»»

Category: global-financeSource: reutersNov 21st, 2018

Indivior: U.S. court rules against generic rival"s appeal

Indivior: U.S. court rules against generic rival"s appeal.....»»

Category: global-financeSource: reutersJul 31st, 2018

Indivior says U.S. court rules against generic rival"s appeal

Indivior says U.S. court rules against generic rival"s appeal.....»»

Category: global-financeSource: reutersJul 31st, 2018

U.S. court expedites Indivior rival Dr. Reddy"s appeal to re-launch generic drug

U.S. court expedites Indivior rival Dr. Reddy"s appeal to re-launch generic drug.....»»

Category: global-financeSource: reutersJul 30th, 2018

British drugmaker Indivior"s shares hit by copycat, new drug worries

British drugmaker Indivior"s shares hit by copycat, new drug worries.....»»

Category: global-financeSource: reutersJul 25th, 2018

Indivior wins preliminary injunction against generic rival

Indivior wins preliminary injunction against generic rival.....»»

Category: global-financeSource: reutersJul 14th, 2018

Indivior says 2018 profit to fall short after U.S. market hit

Indivior says 2018 profit to fall short after U.S. market hit.....»»

Category: global-financeSource: reutersJul 11th, 2018

Indivior gets breather after court extends order blocking generic rival

Indivior gets breather after court extends order blocking generic rival.....»»

Category: global-financeSource: reutersJun 29th, 2018